Dr. Takahashi’s trial will use sheets of retinal pigment epithelium cells, derived from induced pluripotent stem cells. Researchers at the RIKEN Center for Developmental Biology in Kobe, Japan, are currently seeking patients to participate in the study.
More Articles on Ophthalmology:
Billionaire Stephen Wynn Gives $25M for University of Iowa’s Vision Research
Dr. John Kerrison’s Retina Consultants of Charleston Opens New Clinic
Sleep Apnea Could Lead to Glaucoma, Study Says
